Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-209307 |
|---|---|
| Form Type | 4 |
| Filing Date | May 6, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
16,000
Total Value
$134,196.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | May 5, 2026 | Exercise/Conversion | 4,000 | $4.30 | $17,200.00 | 174,844 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | May 5, 2026 | Sale | 7,800 | $14.60 | $113,880.00 | 167,044 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | May 5, 2026 | Sale | 200 | $15.58 | $3,116.00 | 166,844 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | May 5, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 116,987 | Direct | โ | View Details |